Dr. Leonard Pinchuk is a world renowned expert in the field of biomaterials and medical devices with over 100 U.S. patents. His accomplishments include the invention (or co-invention) of the modern-day angioplasty balloon, the helical stent used on most stent-grafts, the modular stent-graft used to repair abdominal aortic aneurysms, polycarbonate urethanes for use in medicine, SIBS for implant applications, Boston Scientific’s TAXUS drug-eluting coronary stent, the InnFocus MicroShunt™ for the treatment of glaucoma, the Surefire Catheter for treating liver tumors and the next generation intraocular lens material.
He began his career at Cordis Corporation in 1983 and left to co-found Corvita Corporation in 1987 where they pioneered the field of stent-grafts. After completing a successful IPO on the NASDAQ in 1994, Corvita was purchased by Pfizer, Inc. and then Boston Scientific where he became the first-named inventor on the TAXUS drug-eluting coronary stent, the largest product launch in the history of medical devices. Dr. Pinchuk founded Innovia LLC in 2002, which spun off InnFocus in 2004 and Innolene in 2006. He also co-founded Surefire Medical in 2010. He currently serves as president and CEO of Innovia, CSO of InnFocus, Inc. and also enjoys an appointment as Distinguished Research Professor of Biomedical Engineering at the University of Miami. Dr. Pinchuk is also on the advisory board of the University of Maryland, College Park; the University of Miami, Miami, FL; and, McGill University, Montreal, Quebec, Canada.
Dr. Pinchuk received a B.Sc. in chemistry from McGill University in 1976, a Ph.D. interdisciplinary in Engineering and Chemistry from the University of Miami in 1984 and an honorary Doctor of Science degree from McGill University in 2005. He was inducted into AIMBE in 2007, he received the Greater Miami Chamber of Commerce Health Care Heroes Award in 2008 and was inducted into the National Academy of Engineering in 2012.